Aventa Genomics introduces NGS test for solid tumours
Aventa Genomics has launched its next-generation sequencing (NGS) test, Aventa FusionPlus, to identify gene fusions and translocations.
Aventa Genomics has launched its next-generation sequencing (NGS) test, Aventa FusionPlus, to identify gene fusions and translocations.
Speakers emphasised the need for classification and approval of devices, and effective licencing and quality control at BioTrinity 2024.
Learn more about how prostate cancer is detected, risk factors, and treatments on our full video. Watch the full video on prostate cancer by clicking…
Global life sciences company Labcorp has announced the first commercially available GFAP blood biomarker test in the US.
The TELE-ACS designed to test SHL Telemedicine’s SmartHeart system was also able to significant drop emergency hospital visits by 41%.
The NAVIGATE-PF study will enrol 30 subjects across Europe with paroxysmal or persistent atrial fibrillation (AF).
Aventa Genomics has launched its next-generation sequencing (NGS) test, Aventa FusionPlus, to identify gene fusions and translocations.
The robotic surgery platform is aimed at speeding up aortic valve replacement surgeries whilst cutting down on staff.
Current North America and Europe market leader drops ventilator product lines, pivots to form Acute Care and Monitoring business.
The automated closed loop system delivered improved glycaemic and patient-reported outcomes versus traditional tech.
Medical devices in Industry 4.0 are providing healthcare providers with greater amounts of data for more accurate diagnostics, but can fourth-generation connectivity keep up?